Noveko International IncTSX: EKO

/C O R R E C T I O N from Source - Noveko International Inc./

· Issued by Noveko International Inc via CNW

In c7525 transmitted at 9:17e today, an error occurred in the title.

"Noveko International Inc. Continues to Growth" should have read "Noveko

International Inc. Continues to Expand". Corrected copy follows:

Noveko International Inc. Continues to Expand - Two Acquisitions in

Progress: Groupe Conseils Micron-Air inc. and SARL Noveko Algerie

EKO / TSX Venture Exchange

MONTREAL, June 25 /CNW Telbec/ - Noveko International Inc. ("Noveko") announces the acceptance of its offer to purchase all the issued and outstanding shares of Groupe Conseils Micron-Air inc. ("Micron-Air"), a designer and manufacturer of air quality systems marketed under the EPURAIR (TM) brand and targeted to the residential market.

The Micron-Air product line includes portable or central HEPA air exchangers and air purifiers, filtration systems for furnaces, central air humidifiers with an ecological water management system, and a ventilator and ventilation duct cleaner and sanitizer. Micron-Air manufactures its products using the most advanced manufacturing techniques and operates two plants located in McMasterville, Quebec. At Micron-Air, specialists in engineering and health collaborate on a continuous basis to design top-of-the-line systems. EPURAIR(TM) products are marketed in Quebec, increasingly in the United States and also in France and China.

"The acquisition of Micron-Air will enable us to integrate an innovative company with an excellent reputation, and whose high-quality products are complementary to our biomedical and environmental activities. We expect to achieve cross-selling and significant business synergies by combining our distribution networks," indicated Andre Leroux, Chairman of the Board and Chief Executive Officer of Noveko.

The purchase price will be CA$600,000 in cash, plus 600,000 Class A shares of Noveko, to be divided between Simon Labrecque and Gestion Simon Labrecque inc., the two shareholders of Micron-Air. The $600,000 cash consideration will be increased by $1.00 for each shareholders' equity dollar above $600,000 on the closing date, up to a maximum shareholders' equity amount of $800,000. Subsequent to the scheduled closing of this acquisition by early August 2008, Simon Labrecque will continue to act as President of Micron-Air which will become an operating subsidiary of Noveko. The closing of such acquisition is notably subject to thorough due diligence of Micron-Air and to the consent of the TSX Venture Exchange. The 600,000 Class A shares to be issued pursuant to this transaction will be subject to a standard four-month holding period.

Offer to Purchase SARL NOVEKO ALGERIE

-------------------------------------

Noveko also announces the acceptance of its offer to purchase all the issued and outstanding shares of SARL Noveko Algerie ("Noveko Algerie"), a medical equipment import company located in Zeralda Alger, Algeria, 50% of which is owned by Mourad Ramdane, President, and 50% by BLT Capital Inc., itself equally held by three officers of Noveko, namely Andre Leroux, Alain Bolduc and Jacques Tessier.

"With Noveko Algerie within our Group, we can more intensively develop the Algeria, Maghreb in general and Middle East markets, which hold great potential for our subsidiaries' various product lines. Its mission and operations are therefore set to expand and be reinforced in the future. When Noveko Algerie was incorporated, our Board of Directors had not authorized the acquisition by Noveko of 50% of its shares as there was no certainty that such acquisition in these markets would be profitable for Noveko. However, we had permitted this company to use "Noveko" in its corporate name in order to seriously test and to distribute our products in these markets. The Board of Directors is now satisfied with Noveko Algerie's results and therefore decided to authorize the acquisition thereof," indicated Andre Leroux.

The transaction will be settled by way of 240,000 Class A shares of Noveko, to be divided equally between Mourad Ramdane and BLT Capital Inc. The closing of such acquisition is notably subject to thorough due diligence of Noveko Algerie and to the consent of the TSX Venture Exchange. Subsequent to the scheduled closing of the transaction on or about July 15, 2008, Mourad Ramdane will continue to act as President of Noveko Algerie within the Noveko Group. All the Class A shares issued pursuant to this transaction will be subject to a standard four-month holding period.

Profile

-------

Noveko International Inc. is a public holding company. Currently, its operating subsidiaries are S.A.S. ECM, Noveko Inc., Laboratoire SyMa Inc., Bolduc Leroux Inc. and Magnum Pharmaceutics Inc. ECM specializes in portable real-time ultrasound scanners for veterinary and human medicine. Noveko Inc. develops biomedical and environmental products derived from its patented antimicrobial filtration technology (Noveko(TM) antimicrobial face masks and air filters). SyMa specializes in sanitizers, sold under the Azuro(TM) brand. BLI is involved in the custom processing and distribution of steel products based on client specifications. Magnum acts as a manufacturer sales agent for the Noveko Group's biomedical and environmental products and sanitizers and for other manufacturers.

The information set forth in this press release includes certain forward-looking statements. Such statements are based on assumptions exposed to major risks and uncertainties. Although Noveko deems the expectations reflected in these forward-looking statements to be reasonable, the Company cannot provide any guarantee as to the materialization of the expectations reflected in these forward-looking statements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Noveko International Inc on 6ix

Earlier from Noveko International

Later from Noveko International

All Noveko International news releases